Arcoral Pharma (Arcoral Tab) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Arcoral Pharma (Arcoral Tab) General Information
Description
Rights of an oncology support care drug. The drug is a topical oral agent used in the treatment of conditions resulting in reduced salivary flow such as xerostomia and hyposalivation caused by radiotherapy, mucositis, surgery, Sjögrens syndrome or obstruction of the salivary glands.
Contact Information
Corporate Office
- Hokksund
- Norway
Corporate Office
- Hokksund
- Norway
Arcoral Pharma (Arcoral Tab) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Arcoral Pharma (Arcoral Tab) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Arcoral Pharma (Arcoral Tab) FAQs
-
Where is Arcoral Pharma (Arcoral Tab) headquartered?
Arcoral Pharma (Arcoral Tab) is headquartered in Hokksund, Norway.
-
What industry is Arcoral Pharma (Arcoral Tab) in?
Arcoral Pharma (Arcoral Tab)’s primary industry is Buildings and Property.
-
Is Arcoral Pharma (Arcoral Tab) a private or public company?
Arcoral Pharma (Arcoral Tab) is a Private company.
-
What is Arcoral Pharma (Arcoral Tab)’s current revenue?
The current revenue for Arcoral Pharma (Arcoral Tab) is .
-
Who are Arcoral Pharma (Arcoral Tab)’s investors?
Arcoral Pharma has invested in Arcoral Pharma (Arcoral Tab).
-
When was Arcoral Pharma (Arcoral Tab) acquired?
Arcoral Pharma (Arcoral Tab) was acquired on 12-Apr-2016.
-
Who acquired Arcoral Pharma (Arcoral Tab)?
Arcoral Pharma (Arcoral Tab) was acquired by EUSA Pharma (UK).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process